ArticleFrontiers in neuroscience2025

Characterization of the white matter networks in schizophrenia patients with metabolic syndrome undergoing risperidone or clozapine treatment.

Xinyan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.